200
Participants
Start Date
July 16, 2022
Primary Completion Date
June 9, 2023
Study Completion Date
March 14, 2024
Abrocitinib 100 mg
Orally administered, abrocitinib 100 mg tablets QD
Abrocitinib 200 mg
Orally administered, abrocitinib 200 mg tablets QD.
Maharaja Agrasen Hospital, New Delhi
All India Institute of Medical Sciences, New Delhi
Sir Ganga Ram Hospital, New Delhi
Postgraduate Institute of Medical Education & Research, Chandigarh
Apex Hospitals Pvt. Ltd., Jaipur
S. P. Medical College & A. G. Hospitals, Bikaner
Government Medical College & Shri Sayajirao General Hospital, Vadodara
Nirmal Hospital Pvt Ltd., Surat
Jehangir Clinical Development Centre Pvt. Ltd., Pune
Assured Care Plus Hospital, Nashik
Mahatma Gandhi Mission's Medical College & Hospital, Aurangabad
Orange City Hospital and Research Institute, Nagpur
RajaRajeswari Medical College and Hospital, Bengaluru
Father Muller Medical College Hospital, Mangalore
Calcutta School of Tropical Medicine, Kolkata
Lead Sponsor
Pfizer
INDUSTRY